The lower starting price makes treatment more accessible
The Bottom Line Hitting protein goals can be hard, especially for anyone on a GLP-1 medication
Microdosing may not offer the same outcomes as FDA-approved GLP-1 RAs
Beyond its well-documented antioxidant effects, PYC exhibits anti-inflammatory, immunomodulatory, antiviral, and anticancer properties, making it a promising candidate for adjunctive management of viral infections characterized by ROS generation, inflammation, and immune dysregulation
"Novo Sees Generic Ozempic Delayed in China Until Next Year", SWI swissinfo , 6 May 2026, archived from the original on 29 May 2026 "Drugmaker seeks approval for China's first biosimilar Ozempic"
The proportion of people with Type 2 diabetes rises with age, too, to nearly 30% at age 65 and older